Health Disparities Subcommittee, Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC): Teleconference, 36730 [E9-17674]
Download as PDF
36730
Federal Register / Vol. 74, No. 141 / Friday, July 24, 2009 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel, July 28,
2009, 11 a.m. to July 28, 2009, 3 p.m.,
National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD, 20892
which was published in the Federal
Register on June 26, 2009, 74 FR 30595–
30596.
This meeting will be an AED held on
July 27, 2009, 9 a.m. to July 28, 2009,
11:55 p.m. The meeting location
remains the same. The meeting is closed
to the public.
Dated: July 20, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–17738 Filed 7–23–09; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
srobinson on DSKHWCL6B1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Role of Pulmonary
Collectins in Innate Immunity and
Bronchopulmonary Dysplasia.
Date: August 7, 2009.
Time: 12 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Room 5B01, Rockville,
MD 20852 (Telephone Conference Call).
Contact Person: Peter Zelazowski, PhD,
Scientific Review Officer, Division of
18:55 Jul 23, 2009
Jkt 217001
Dated: July 20, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–17737 Filed 7–23–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Nov<24>2008
Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6100 Executive
Boulevard, Rm. 5B01, Bethesda, MD 20892–
7510, 301–435–6902.
peter.zelazowski@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
NHLBI Proteomic Centers.
Date: September 24–25, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Sheraton Columbia Town Center
Hotel, 10207 Wincopin Circle, Columbia, MD
21044.
Contact Person: Katherine M Malinda,
PhD, Scientific Review Officer, Review
Branch/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7198, Bethesda, MD 20892–7924, 301–435–
0297, malindakm@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
Dated: July 20, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–17736 Filed 7–23–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Health Disparities Subcommittee,
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention (CDC): Teleconference
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), CDC announces the
following meeting for the
aforementioned subcommittee.
Name: Health Disparities Subcommittee,
Advisory Committee to the Director, CDC.
Time and Date: 9 a.m.–11 a.m., August 17,
2009.
Place: This meeting will be held by
conference call. The call in number is (877)
394–7734 and enter passcode 9363147.
Status: Open to the public, limited only by
the availability of telephone ports.
Purpose: The subcommittee will provide
counsel to the ACD, CDC on CDC’s efforts to
address health disparities in achieving the
agency’s overarching health impact goals.
Matters to be Discussed: Agenda items will
include a policy brief on health equity and
social determinants of health; collaboration
and update with the ACD Ethics
Subcommittee; and collaboration with the
CDC Health Equity Workgroup.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Walter W. Williams, M.D., M.P.H.,
Designated Federal Officer, Health
Disparities Subcommittee, Advisory
Committee to the Director, CDC, 1600 Clifton
Road, NE., M/S E–67, Atlanta, Georgia 30333.
Telephone 404/498–2310, e-mail:
WWilliams@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: July 17, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–17674 Filed 7–23–09; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\24JYN1.SGM
24JYN1
Agencies
[Federal Register Volume 74, Number 141 (Friday, July 24, 2009)]
[Notices]
[Page 36730]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-17674]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Health Disparities Subcommittee, Advisory Committee to the
Director (ACD), Centers for Disease Control and Prevention (CDC):
Teleconference
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), CDC announces the following meeting for
the aforementioned subcommittee.
Name: Health Disparities Subcommittee, Advisory Committee to the
Director, CDC.
Time and Date: 9 a.m.-11 a.m., August 17, 2009.
Place: This meeting will be held by conference call. The call in
number is (877) 394-7734 and enter passcode 9363147.
Status: Open to the public, limited only by the availability of
telephone ports.
Purpose: The subcommittee will provide counsel to the ACD, CDC
on CDC's efforts to address health disparities in achieving the
agency's overarching health impact goals.
Matters to be Discussed: Agenda items will include a policy
brief on health equity and social determinants of health;
collaboration and update with the ACD Ethics Subcommittee; and
collaboration with the CDC Health Equity Workgroup.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Walter W. Williams, M.D.,
M.P.H., Designated Federal Officer, Health Disparities Subcommittee,
Advisory Committee to the Director, CDC, 1600 Clifton Road, NE., M/S
E-67, Atlanta, Georgia 30333. Telephone 404/498-2310, e-mail:
WWilliams@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: July 17, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E9-17674 Filed 7-23-09; 8:45 am]
BILLING CODE 4163-18-P